Table of Contents
ISRN Ophthalmology
Volume 2014, Article ID 950975, 7 pages
http://dx.doi.org/10.1155/2014/950975
Research Article

Outcomes and Control Rates for I-125 Plaque Brachytherapy for Uveal Melanoma: A Community-Based Institutional Experience

1Department of Radiation Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA
2Department of Radiation Oncology, Intermountain Medical Center, 5131 Cottonwood Street, Murray, UT 84107, USA
3Rocky Mountain Retina Associates, Murray, UT 84107, USA
4Retina Associates of Utah, Murray, UT 84107, USA

Received 31 December 2013; Accepted 11 February 2014; Published 9 March 2014

Academic Editors: M. N. Burnier Jr., M. Nakazawa, and H. Quiroz-Mercado

Copyright © 2014 Aaron Wagner et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. D. Singh, L. Bergman, and S. Seregard, “Uveal melanoma: epidemiologic aspects,” Ophthalmology Clinics of North America, vol. 18, no. 1, pp. 75–84, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. C. L. Shields, S. Kaliki, M. Furuta, A. Mashayekhi, and J. A. Shields, “Clinical spectrum and prognosis of uveal melanoma based on age at presentation in 8,033 cases,” Retina, vol. 32, pp. 1363–1372, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. Collaborative Ocular Melanoma Study Group, “The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report no. 28,” Archives of Ophthalmology, vol. 124, no. 12, pp. 1684–1693, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. B. S. Hawkins and Collaborative Ocular Melanoma Study Group, “The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma: IV. Ten-year mortality findings and prognostic factors. COMS report number 24,” American Journal of Ophthalmology, vol. 138, pp. 936–951, 2004. View at Google Scholar
  5. J.-P. Caujolle, H. Mammar, E. Chamorey, F. Pinon, J. Herault, and P. Gastaud, “Proton beam radiotherapy for uveal melanomas at nice teaching hospital: 16 years' experience,” International Journal of Radiation Oncology Biology Physics, vol. 78, no. 1, pp. 98–103, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Nag, J. M. Quivey, J. D. Earle, D. Followill, J. Fontanesi, and P. T. Finger, “The American Brachytherapy Society recommendations for brachytherapy of uveal melanomas,” International Journal of Radiation Oncology Biology Physics, vol. 56, no. 2, pp. 544–555, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. P. de Potter, C. L. Shields, J. A. Shields, J. R. Cater, and L. W. Brady, “Plaque radiotherapy for juxtapapillary choroidal melanoma: visual acuity and survival outcome,” Archives of Ophthalmology, vol. 114, no. 11, pp. 1357–1365, 1996. View at Google Scholar · View at Scopus
  8. K. Gündüz, C. L. Shields, J. A. Shields, J. Cater, J. E. Freire, and L. V. Brady, “Radiation retinopathy following plaque radiotherapy for posterior uveal melanoma,” Archives of Ophthalmology, vol. 117, no. 5, pp. 609–614, 1999. View at Google Scholar · View at Scopus
  9. J. M. Quivey, D. H. Char, T. L. Phillips, K. A. Weaver, J. R. Castro, and S. M. Kroll, “High intensity 125-iodine (125I) plaque treatment of uveal melanoma,” International Journal of Radiation Oncology Biology Physics, vol. 26, no. 4, pp. 613–618, 1993. View at Google Scholar · View at Scopus
  10. C. L. Shields, J. A. Shields, J. Cater et al., “Plaque radiotherapy for uveal melanoma: long-term visual outcome in 1106 consecutive patients,” Archives of Ophthalmology, vol. 118, no. 9, pp. 1219–1228, 2000. View at Google Scholar · View at Scopus
  11. K. L. Leonard, N. L. Gagne, J. E. Mignano, J. S. Duker, E. A. Bannon, and M. J. Rivard, “A 17-year retrospective study of institutional results for eye plaque brachytherapy of uveal melanoma using 125I, 103Pd, and 131Cs and historical perspective,” Brachytherapy, vol. 10, no. 4, pp. 331–339, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. A. W. Jensen, I. A. Petersen, R. W. Kline, S. L. Stafford, P. J. Schomberg, and D. M. Robertson, “Radiation complications and tumor control after 125I plaque brachytherapy for ocular melanoma,” International Journal of Radiation Oncology Biology Physics, vol. 63, no. 1, pp. 101–108, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Jones, E. Gore, W. Mieler et al., “Posttreatment visual acuity in patients treated with episcleral plaque therapy for choroidal melanomas: dose and dose rate effects,” International Journal of Radiation Oncology Biology Physics, vol. 52, no. 4, pp. 989–995, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Stack, M. Elder, A. Abdelaal, R. Hidajat, and R. Clemett, “New Zealand experience I125 brachytherapy for choroidal melanoma,” Clinical and Experimental Ophthalmology, vol. 33, no. 5, pp. 490–494, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. J. M. Quivey, J. Augsburger, L. Snelling, and L. W. Brady, “125I plaque therapy for uveal melanoma: analysis of the impact of time and dose factors on local control,” Cancer, vol. 77, no. 11, pp. 2356–2362, 1996. View at Google Scholar · View at Scopus
  16. M. Diener-West, J. D. Earle, S. L. Fine et al., “The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings: COMS report no. 18,” Archives of Ophthalmology, vol. 119, no. 7, pp. 969–982, 2001. View at Google Scholar · View at Scopus
  17. A. D. Singh, M. E. Turell, and A. K. Topham, “Uveal melanoma: trends in incidence, treatment, and survival,” Ophthalmology, vol. 118, no. 9, pp. 1881–1885, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. D. H. Char, S. Kroll, T. L. Phillips, and J. M. Quivey, “Late radiation failures after iodine 125 brachytherapy for uveal melanoma compared with charged-particle (proton or helium ion) therapy,” Ophthalmology, vol. 109, no. 10, pp. 1850–1854, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. C. L. Shields, M. Naseripour, J. Cater et al., “Plaque radiotherapy for large posterior uveal melanomas (≥8-mm thick) in 354 consecutive patients,” Ophthalmology, vol. 109, no. 10, pp. 1838–1849, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Packer, M. Rotman, and P. Salanitro, “Iodine-125 irradiation of choroidal melanoma. Clinical experience,” Ophthalmology, vol. 91, no. 12, pp. 1700–1708, 1984. View at Google Scholar · View at Scopus
  21. S. Packer, S. Stoller, M. L. Lesser, F. S. Mandel, P. T. Finger, and D. M. Robertson, “Long-term results of iodine 125 irradiation of uveal melanoma,” Ophthalmology, vol. 99, no. 5, pp. 767–774, 1992. View at Google Scholar · View at Scopus
  22. L. M. Jampol, C. S. Moy, T. G. Murray et al., “The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS report no. 19,” Ophthalmology, vol. 109, pp. 2197–2206, 2002. View at Google Scholar
  23. S. Nag, D. Wang, H. Wu, C. J. Bauer, R. B. Chambers, and F. H. Davidorf, “Custom-made “Nag” eye plaques for 125I brachytherapy,” International Journal of Radiation Oncology Biology Physics, vol. 56, no. 5, pp. 1373–1380, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. M. S. Sagoo, C. L. Shields, A. Mashayekhi et al., “Plaque radiotherapy for juxtapapillary choroidal melanoma: tumor control in 650 consecutive cases,” Ophthalmology, vol. 118, no. 2, pp. 402–407, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. J. M. Henk, R. A. F. Whitelocke, A. P. Warrington, and E. M. Bessell, “Radiation dose to the lens and cataract formation,” International Journal of Radiation Oncology Biology Physics, vol. 25, no. 5, pp. 815–820, 1993. View at Google Scholar · View at Scopus
  26. B. Emami, J. Lyman, A. Brown et al., “Tolerance of normal tissue to therapeutic irradiation,” International Journal of Radiation Oncology Biology Physics, vol. 21, no. 1, pp. 109–122, 1991. View at Google Scholar · View at Scopus
  27. J. C. Wen, S. C. Oliver, and T. A. McCannel, “Ocular complications following I-125 brachytherapy for choroidal melanoma,” Eye, vol. 23, no. 6, pp. 1254–1268, 2009. View at Publisher · View at Google Scholar · View at Scopus